News Daily News Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas Shelley Wood September 13, 2016
News Daily News Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities Caitlin E. Cox September 08, 2016
News Daily News Las Tendencias en el Desarrollo de Fármacos Cardiovasculares Indican Problemas y Posibilidades Durante la Fase de Desarrollo Caitlin E. Cox September 08, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 Edoxaban Shows Safety, Efficacy for A-fib Patients Undergoing Cardioversion: ENSURE-AF Todd Neale August 30, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Daily News Drug Company Payments to Physicians May Be Influencing Prescribing Todd Neale August 23, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
News Daily News Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI L.A. McKeown August 17, 2016
News Daily News Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR Yael L. Maxwell August 16, 2016
News Daily News Warfarin Control Over Time Is Shaky Even in Those Who Are Initially Stable Todd Neale August 10, 2016
News Daily News A la Larga el Control de la Warfarina es Complicado Incluso en Pacientes Inicialmente Inestables Todd Neale August 10, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016